Biotech Turnaround Fund (BTF)

Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six

Be the first to review

Independent rating of Biotech Turnaround Fund (BTF)

Overall rating:
Not reviewed

About Biotech Turnaround Fund (BTF)

Website:
http://www.btf.eu
Founded:
2000
Number of investments:
7
Number of exits:
1
Headquarters:
Bloemendaal, The Netherlands
Organization type:
Venture Capital

How Biotech Turnaround Fund (BTF) invests

Rounds:
Venture Round, Series D, Series E, Series A
Average ticket size:
5.67M USD
Smallest investment:
2.2M USD
Biggest investment:
9.14M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
Canada, United States
Sectors of interest:
Pharmaceutical, Genetics, Biotechnology, Therapeutics, Medical Device, Medical, Life Science, Biopharma

Portfolio - latest investments by Biotech Turnaround Fund (BTF)
CymaBay Therapeutics
Genizon BioSciences
Galileo Genomics

Founders' reviews of Biotech Turnaround Fund (BTF)

Be the first one to review Biotech Turnaround Fund (BTF).
Nobody reviews Biotech Turnaround Fund (BTF) just yet. Help other founders navigate by writing about your experience with them.
Similar funds